BIA-ALCL: Why Published Risk Estimates Vary
2 Oct 2026 · 0 min
0:15
In this brief segment, Dr. Robert Whitfield MD explains that physician resources report a wide range of incidence estimates for breast implant‑associated anaplastic large‑cell lymphoma (BIA‑ALCL), spanning roughly 1 in 3,800 to 1 in 30,000. He attributes this variability primarily to the difficulty of accurately determining the denominator—the total number of patients exposed to textured implants—making precise risk calculation challenging.
